PCVX · Vaxcyte, Inc. · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-11-11 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Convert↑
|
Common Stock
|
17,000 |
| 2026-11-11 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026. The price reported is a weighted-average price. The shares were sold at prices ranging from $68.76 to $68.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated October 6, 2026 were sold by the Reporting Person. |
Common Stock
|
520 |
| 2026-11-11 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026. The price reported is a weighted-average price. The shares were sold at prices ranging from $67.76 to $68.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
9,345 |
| 2026-11-11 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026. The price reported is a weighted-average price. The shares were sold at prices ranging from $66.76 to $67.755. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
7,135 |
| 2026-11-11 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Stock Option is fully vested and exercisable. |
Stock Option (right to buy)
|
17,000 |
| 2026-11-02 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $60.385 to $61.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price |
Common Stock
|
1,907 |
| 2026-11-02 | Wassil Jim |
CHIEF OPERATING OFFICER |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Stock Option is fully vested and exercisable. |
Stock Option (right to buy)
|
2,250 |
| 2026-11-02 | Cowan Elvia |
SVP, Finance & CAO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $61.425 to $61.92. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
586 |
| 2026-11-02 | Cowan Elvia |
SVP, Finance & CAO |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Stock Option is fully vested and exercisable. |
Stock Option (right to buy)
|
3,000 |
| 2026-11-02 | Cowan Elvia |
SVP, Finance & CAO |
Convert↑
|
Common Stock
|
3,000 |
| 2026-11-02 | Wassil Jim |
CHIEF OPERATING OFFICER |
Convert↑
|
Common Stock
|
2,250 |
| 2026-11-02 | Cowan Elvia |
SVP, Finance & CAO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $60.345 to $61.325. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
2,414 |
| 2026-11-02 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $61.40 to $61.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price |
Common Stock
|
343 |
| 2026-10-05 | Wassil Jim |
CHIEF OPERATING OFFICER |
Convert↑
|
Common Stock
|
18,000 |
| 2026-10-05 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. |
Common Stock
|
18,000 |
| 2026-10-05 | Cowan Elvia |
SVP, Finance & CAO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. |
Common Stock
|
19,000 |
| 2026-10-05 | Wassil Jim |
CHIEF OPERATING OFFICER |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Stock Option is fully vested and exercisable. |
Stock Option (right to buy)
|
18,000 |
| 2026-10-05 | Cowan Elvia |
SVP, Finance & CAO |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Stock Option is fully vested and exercisable. |
Stock Option (right to buy)
|
19,000 |
| 2026-10-05 | Cowan Elvia |
SVP, Finance & CAO |
Convert↑
|
Common Stock
|
19,000 |
| 2026-10-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $56.065 to $56.955. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
2,155 |
| 2026-10-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Stock Option is fully vested and exercisable. |
Stock Option (right to buy)
|
2,250 |
| 2026-10-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Convert↑
|
Common Stock
|
2,250 |
| 2026-10-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $57.09 to $57.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
95 |
| 2026-09-09 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $59.155 to $60.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
1,334 |
| 2026-09-08 | Wassil Jim |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
5,459 |
| 2026-09-08 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
7,651 |
| 2026-09-08 | GUGGENHIME ANDREW |
Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
7,155 |
| 2026-09-08 | PICKERING GRANT |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
17,056 |
| 2026-09-08 | Cowan Elvia |
SVP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
1,327 |
| 2026-09-04 | Jodar Luis |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
1/4 of the shares subject to the option shall vest on August 31, 2027, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
Stock Option (right to buy)
|
88,254 |
| 2026-09-04 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $60.95 to $61.57. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
1,381 |
| 2026-09-04 | Jodar Luis |
Chief Medical Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 1/4 of the shares subject to the award on September 7, 2027 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date. |
Common Stock
|
52,632 |
| 2026-09-02 | GUGGENHIME ANDREW |
Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
1,432 |
| 2026-09-02 | Cowan Elvia |
SVP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
326 |
| 2026-09-02 | Wassil Jim |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
1,432 |
| 2026-09-02 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
659 |
| 2026-09-02 | PICKERING GRANT |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
3,427 |
| 2026-09-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
1,537 |
| 2026-09-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
924 |
| 2026-09-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Convert↑
|
Common Stock
|
2,250 |
| 2026-09-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
713 |
| 2026-09-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Convert↓
Filing footnotes — Stock Option (right to buy) (Direct)
Stock Option is fully vested and exercisable. |
Stock Option (right to buy)
|
2,250 |
| 2026-09-01 | Wassil Jim |
CHIEF OPERATING OFFICER |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025. The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
303 |
| 2026-08-31 | Wassil Jim |
CHIEF OPERATING OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
1,273 |
| 2026-08-31 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
361 |
| 2026-08-31 | Cowan Elvia |
SVP, Finance & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
Common Stock
|
243 |
| 2026-08-31 | GUGGENHIME ANDREW |
Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
1,273 |
| 2026-08-31 | PICKERING GRANT |
Director, CHIEF EXECUTIVE OFFICER |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |
Common Stock
|
2,862 |
| 2026-08-05 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on April 6, 2026. The price reported is a weighted-average price. The shares were sold at prices ranging from $55.00 to $55.255. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Common Stock
|
17,000 |
| 2026-08-05 | Dhaliwal Harpreet S. |
Chief Technical Ops Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 780 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026. |
Common Stock
|
17,000 |